Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle

NCT00404937 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2012-03-06

No results posted yet for this study

Summary

The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation

Conditions

  • Post-surgical Inflammation

Interventions

DRUG

Tobradex (Antibiotic steroid combination)

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2006-12-31
Completion
2006-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00404937 on ClinicalTrials.gov